数字微滴聚合酶链反应与数字多重检测单核苷酸变异在EUS引导下FNA采集的胰腺细胞学标本中的诊断价值
本研究纳入31例胰腺肿块患者的EUS-FNA标本,评估ddPCR检测K-ras及NanoString SNV检测的诊断性能。细胞学检查敏感度63%、特异度100%;ddPCR检测K-ras突变敏感度87%、特异度90%;SNV检测在90%胰腺导管腺癌样本中检出至少1个变异。联合分子检测使细胞学阴性及不确定病例的诊断准确率从74%提升至91%。
要点
- 细胞学检查敏感度63%、特异度100%,ddPCR检测K-ras突变敏感度87%、特异度90%。
- SNV检测在90%胰腺导管腺癌样本中检出至少1个变异,并检出2例ddPCR漏检的K-ras密码子61突变。
- 联合两种分子检测后,细胞学阴性及不确定病例的诊断准确率由74%升至91%。
核心结论
- 将K-ras分析与细胞学评估整合,尤其在细胞学结果不确定的病例中,可提高EUS-FNA对胰腺病变的诊断准确率。
研究设计与样本
- 纳入31例胰腺肿块患者的EUS-FNA标本,其中胰腺导管腺癌22例、慢性胰腺炎7例、胰腺神经内分泌肿瘤2例。
- K-ras检测采用微滴数字聚合酶链反应(ddPCR),并采用NanoString技术的单核苷酸变异(SNV)检测评估突变状态,该检测通过独特条形码探针的数字计数检测24个临床相关基因的97个SNV。
主要发现
- 细胞学检查的总体特异度为100%、敏感度为63%。
- ddPCR检测K-ras突变的敏感度为87%、特异度为90%。
- SNV检测在90%的胰腺导管腺癌样本中检出至少1个变异。
- SNV检测在2例胰腺导管腺癌中检出2个ddPCR漏检的K-ras密码子61突变。
关键数值与推荐
- 细胞学检查单独诊断的总体准确率为74%。
- 对细胞学阴性及不确定结果的病例,结合两种分子检测结果后诊断准确率提高至91%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: EUS-guided FNA is recommended as a first-line procedure for the histopathologic diagnosis of pancreatic cancer. Molecular analysis of EUS-FNA samples might be used as an auxiliary tool to strengthen the diagnosis. The current study aimed to evaluate the diagnostic performances of K-ras testing using droplet digital polymerase chain reaction (ddPCR) and a novel single-nucleotide variant (SNV) assay performed on pancreatic EUS-FNA samples. METHODS: EUS-FNA specimens from 31 patients with pancreatic masses (22 pancreatic ductal adenocarcinomas, 7 chronic pancreatitis, and 2 pancreatic neuroendocrine tumors) were included in the study. K-ras testing was initially performed by ddPCR. In addition, mutational status was evaluated using an SNV assay by NanoString technology, using digital enumeration of unique barcoded probes to detect 97 SNVs from 24 genes of clinical significance. RESULTS: The overall specificity and sensitivity of cytologic examination were 100% and 63%, respectively. K-ras mutation testing was performed using ddPCR, and the sensitivity increased to 87% with specificity 90%. The SNV assay detected at least 1 variant in 90% of pancreatic ductal adenocarcinoma samples; the test was able to detect 2 K-ras codon 61 mutations in 2 cases of pancreatic ductal adenocarcinoma, which were missed by ddPCR. The overall diagnostic accuracy of the cytologic examination alone was 74%, and it increased to 91% when the results of both molecular tests were considered for the cases with negative and inconclusive results. CONCLUSIONS: The current study illustrated that integration of K-ras analysis with cytologic evaluation, especially in inconclusive cases, can enhance the diagnostic accuracy of EUS-FNA for pancreatic lesions.
引用
- Cazacu IM, Semaan A, Stephens B, et al. Diagnostic value of digital droplet polymerase chain reaction and digital multiplexed detection of single-nucleotide variants in pancreatic cytology specimens collected by EUS-guided FNA. Gastrointest Endosc. 2020. PMID: 33058885. doi:10.1016/j.gie.2020.09.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。